-
Signature
-
/s/ Robert J. Mears, by Mindi Zimmer, as Attorney-in-Fact
-
Stock symbol
-
ATOM
-
Transactions as of
-
Jun 1, 2023
-
Transactions value $
-
-$89,645
-
Form type
-
4
-
Date filed
-
6/2/2023, 05:38 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ATOM |
Common Stock |
Sale |
-$8.51K |
-945 |
-0.72% |
$9.00 |
130K |
Jun 1, 2023 |
Direct |
F1 |
transaction |
ATOM |
Common Stock |
Sale |
-$2.24K |
-249 |
-0.19% |
$9.00 |
129K |
Jun 1, 2023 |
Direct |
F1 |
transaction |
ATOM |
Common Stock |
Sale |
-$4.55K |
-505 |
-0.39% |
$9.00 |
129K |
Jun 1, 2023 |
Direct |
F1 |
transaction |
ATOM |
Common Stock |
Sale |
-$1.06K |
-118 |
-0.09% |
$9.00 |
129K |
Jun 1, 2023 |
Direct |
F1 |
transaction |
ATOM |
Common Stock |
Options Exercise |
$39K |
+10K |
+7.77% |
$3.90 |
139K |
Jun 1, 2023 |
Direct |
F2 |
transaction |
ATOM |
Common Stock |
Sale |
-$88.1K |
-10K |
-7.21% |
$8.81 |
129K |
Jun 1, 2023 |
Direct |
F2 |
transaction |
ATOM |
Common Stock |
Sale |
-$24.2K |
-2.8K |
-2.18% |
$8.64 |
126K |
Jun 2, 2023 |
Direct |
F2 |
holding |
ATOM |
Common Stock |
|
|
|
|
|
2.67K |
Jun 1, 2023 |
by Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ATOM |
Non-Qualified Stock Option (right to buy) |
Options Exercise |
$0 |
-10K |
-21.31% |
$0.00 |
36.9K |
Jun 1, 2023 |
Common Stock |
10K |
$3.90 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: